Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

258 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells.
Ottaiano A, di Palma A, Napolitano M, Pisano C, Pignata S, Tatangelo F, Botti G, Acquaviva AM, Castello G, Ascierto PA, Iaffaioli RV, Scala S. Ottaiano A, et al. Among authors: scala s. Cancer Immunol Immunother. 2005 Aug;54(8):781-91. doi: 10.1007/s00262-004-0636-3. Epub 2004 Dec 11. Cancer Immunol Immunother. 2005. PMID: 15592929 Free PMC article.
Prospective clinical trials of biotherapies in solid tumors: a 5-year survey.
Ottaiano A, Mollo E, Di Lorenzo G, Pisano C, Di Maio M, Barletta E, Pensabene M, Segati R, Bullian P, Nasti G, Bryce J, Scala S, Castello G, Ascierto PA. Ottaiano A, et al. Among authors: scala s. Cancer Immunol Immunother. 2005 Jan;54(1):44-50. doi: 10.1007/s00262-004-0567-z. Cancer Immunol Immunother. 2005. PMID: 15693138 Free PMC article. Review.
Temozolomide and cisplatin in avdanced malignant melanoma.
Daponte A, Ascierto PA, Gravina A, Melucci M, Scala S, Ottaiano A, Simeone E, Palmieris G, Comella G. Daponte A, et al. Among authors: scala s. Anticancer Res. 2005 Mar-Apr;25(2B):1441-7. Anticancer Res. 2005. PMID: 15865103 Free article. Clinical Trial.
Adjuvant treatment of malignant melanoma: where are we?
Ascierto PA, Scala S, Ottaiano A, Simeone E, de Michele I, Palmieri G, Castello G. Ascierto PA, et al. Among authors: scala s. Crit Rev Oncol Hematol. 2006 Jan;57(1):45-52. doi: 10.1016/j.critrevonc.2005.05.002. Epub 2005 Jun 28. Crit Rev Oncol Hematol. 2006. PMID: 15990330 Review.
Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies.
Ascierto PA, Scala S, Castello G, Daponte A, Simeone E, Ottaiano A, Beneduce G, De Rosa V, Izzo F, Melucci MT, Ensor CM, Prestayko AW, Holtsberg FW, Bomalaski JS, Clark MA, Savaraj N, Feun LG, Logan TF. Ascierto PA, et al. Among authors: scala s. J Clin Oncol. 2005 Oct 20;23(30):7660-8. doi: 10.1200/JCO.2005.02.0933. J Clin Oncol. 2005. PMID: 16234528 Clinical Trial.
Soluble interleukin-2 receptor in stage I-III melanoma.
Ottaiano A, Leonardi E, Simeone E, Ascierto PA, Scala S, Calemma R, Bryce J, Caracò C, Satriano RA, Gianfranco N, Franco R, Botti G, Castello G. Ottaiano A, et al. Among authors: scala s. Cytokine. 2006 Feb 7;33(3):150-5. doi: 10.1016/j.cyto.2006.01.002. Epub 2006 Mar 6. Cytokine. 2006. PMID: 16517174
258 results